Skip to content
Expres2ion Biotech

Expres2ion Biotech

Investor Relations

  • News & Events
    • Press Releases
    • Upcoming Events
    • Presentations
    • Financial Calendar
  • Financials
    • Financial reports
  • Governance
    • Articles of Association
    • Management Team
    • Board of Directors
    • General Meetings
    • Company Description
  • Stock Information
    • Stock Quote & Largest Shareholders
    • Analyst Reports
    • IPO and Rights Issues
      • Rights issue 2026
      • Rights Issue 2024
      • Rights Issue 2023
      • Rights Issue 2022
      • Rights Issue 2020
      • Rights Issue 2018
      • Rights Issue 2017
      • Rights Issue 2016 (IPO)
  • Corporate Site

Nyemission 2017

  • Home
  • Nyemission 2017

Nyemission 2017

Swedish

Memorandum 2017 (pdf)

Teaser 2017 (pdf)

Anmälningssedel  2017 (pdf)

 

English Translations

In case of any discrepancies to the Swedish original, the Swedish text shall prevail

Teaser 2017 (pdf)

Subscription form 2017 (pdf)


Copyright 2010 - All Rights Reserved

EXPRES2ION BIOTECH HOLDING AB
Registration number: 559033-3729
c/o Mindpark
Rönnowsgatan 8C
SE-252 25 Helsingborg, Sweden

R&D
ExpreS2ion Biotechnologies ApS:
CVR/VAT: DK32770487
Agern Allé 1
DK-2970 Hørsholm, Denmark

INVESTOR RELATIONS
investor@expres2ionbio.com

Contact investor relations

MORE INFO
Privacy Policy
Terms & General Conditions
Legal Notice & Disclaimer

Copyright © 2026 Expres2ion Biotech All rights reserved. Theme: Flash by ThemeGrill. Powered by WordPress